158 related articles for article (PubMed ID: 939035)
1. The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization.
Devey ME; Wilson DV; Wheeler AW
Clin Allergy; 1976 May; 6(3):227-36. PubMed ID: 939035
[TBL] [Abstract][Full Text] [Related]
2. IgE, IgG and patient-self tests during slow hyposensitization to grass pollen.
Blair H; Ezeoke A; Hobbs JR
Clin Allergy; 1975 Sep; 5(3):263-70. PubMed ID: 1182987
[TBL] [Abstract][Full Text] [Related]
3. [IgG4 antibodies to the allergens of grass and tree pollens in pollinosis patients: their diagnostic and prognostic significance].
Chernokhvostova EV; Kotova TS; German GP; Atovmian OI
Ter Arkh; 1990; 62(11):111-4. PubMed ID: 1710073
[TBL] [Abstract][Full Text] [Related]
4. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the clinical and immunological effects of an alum-precipitated five-grass extract with a conjugated two-grass extract in the desensitization of hay fever.
Dorward AJ; Waclawski E; Kerr JW
Clin Allergy; 1984 Nov; 14(6):561-70. PubMed ID: 6391736
[TBL] [Abstract][Full Text] [Related]
6. IgG4 antibodies in hay fever patients. Difference in IgG4 response to tree pollen and grass pollen allergens.
Chernokhvostova EV; Kotova TS; German GP; Atovmian OI
Int Arch Allergy Appl Immunol; 1990; 92(3):217-22. PubMed ID: 2276839
[TBL] [Abstract][Full Text] [Related]
7. Immunologic changes during specific treatment of the atopic state. 3. The immunologic response in the course of hyposensitization of hay fever patients with aqueous and alum - pyridine allergens.
Zavázal V; Stajner A
Acta Allergol; 1970 Apr; 25(1):18-24. PubMed ID: 5468237
[No Abstract] [Full Text] [Related]
8. Subclass typing of IgG antibodies formed by grass pollen-allergic patients during immunotherapy.
van der Giessen M; Homan WL; van Kernbeek G; Aalberse RC; Dieges PH
Int Arch Allergy Appl Immunol; 1976; 50(5):625-40. PubMed ID: 773842
[TBL] [Abstract][Full Text] [Related]
9. Specific IgE and IgG antibody responses in children to timothy pollen components during immunotherapy.
Nordvall SL; Renck B; Einarsson R
Allergy; 1989 Aug; 44(6):380-4. PubMed ID: 2802111
[TBL] [Abstract][Full Text] [Related]
10. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies.
James LK; Shamji MH; Walker SM; Wilson DR; Wachholz PA; Francis JN; Jacobson MR; Kimber I; Till SJ; Durham SR
J Allergy Clin Immunol; 2011 Feb; 127(2):509-516.e1-5. PubMed ID: 21281875
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of grass pollen to hay fever patients. An efficacy study in oral hyposensitization.
Taudorf E; Laursen LC; Djurup R; Kappelgaard E; Pedersen CT; Søborg M; Wilkinson P; Weeke B
Allergy; 1985 Jul; 40(5):321-35. PubMed ID: 3898904
[TBL] [Abstract][Full Text] [Related]
12. Orally administered grass pollen.
Taudorf E; Weeke B
Allergy; 1983 Nov; 38(8):561-4. PubMed ID: 6362471
[TBL] [Abstract][Full Text] [Related]
13. [IgE and IgG antibody response in patients with type I allergy to birch pollen].
Rumpold H; Jarolim E; Bonitz W; Tejkl M; Breitenbach M; Scheiner O; Kraft D
Wien Klin Wochenschr; 1989 Feb; 101(3):107-10. PubMed ID: 2922932
[TBL] [Abstract][Full Text] [Related]
14. [Hyposensitization with cross-reacting pollen allergens].
Karl S; Rakoski J
Z Hautkr; 1988; 63 Suppl 4():55-7. PubMed ID: 3252627
[TBL] [Abstract][Full Text] [Related]
15. Hyposensitization therapy with whole pollen extract or purified allergens monitored by immunoblotting.
Jarolim E; Matthiesen F; Skov PS; Tejkl M; Oesterballe O; Poulsen LK
Int Arch Allergy Appl Immunol; 1990; 92(3):254-64. PubMed ID: 1703516
[TBL] [Abstract][Full Text] [Related]
16. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
17. IgG subclass antibody markers in grass pollen immunotherapy.
Moss RB
N Engl Reg Allergy Proc; 1987; 8(6):409-15. PubMed ID: 3325818
[TBL] [Abstract][Full Text] [Related]
18. Relationship between allergic status and specificity of IgG antibody to inhaled allergens: the grass pollen model.
Michils A; Vervier I; Choufani G; Gossart B; Duchateau J
Clin Exp Allergy; 1999 Jun; 29(6):832-9. PubMed ID: 10336601
[TBL] [Abstract][Full Text] [Related]
19. Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy.
Ball T; Sperr WR; Valent P; Lidholm J; Spitzauer S; Ebner C; Kraft D; Valenta R
Eur J Immunol; 1999 Jun; 29(6):2026-36. PubMed ID: 10382766
[TBL] [Abstract][Full Text] [Related]
20. Hyposensitization of patients with allergic rhinitis by intranasal administration of chemically modified grass pollen allergen. A pilot study.
Deuschl H; Johansson GO
Acta Allergol; 1977 Aug; 32(4):248-62. PubMed ID: 578362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
